- Complete therapeutic response to anti-PD1 therapy in patient with advanced melanoma and resistance to targeted therapy of BRAF inhibitors2018 | First Faculty of Medicine
- Pembrolizumab in the treatment of non-small-cell lung cancer2016 | Publication without faculty affiliation
- A long-term survivor female patient with metastatic melanoma after treatment with pembrolizumab in the third line2020 | First Faculty of Medicine
- Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium2024 | Second Faculty of Medicine
- Cemiplimab as a hope for a young patient with aggressive squamous cell carcinoma of the sacrococcygeal region2021 | Faculty of Medicine in Pilsen
- Advances in the treatment of metastatic melanoma2018 | First Faculty of Medicine
- Pembrolizumab - another successfull therapy in the treatment of melanoma2016 | Third Faculty of Medicine
- Hodgkin lymphoma - hendless story Hodgkin lymphoma - endless story2019 | Third Faculty of Medicine
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries2018 | Third Faculty of Medicine
- European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 20232023 | Third Faculty of Medicine
